# DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures

> **NCT05116345** · PHASE4 · UNKNOWN · sponsor: **Brian Jerkins, MD** · enrollment: 30 (estimated)

## Conditions studied

- Glaucoma Following Surgery

## Interventions

- **DRUG:** DEXTENZA
- **DRUG:** Topical Dexamethasone

## Key facts

- **NCT ID:** NCT05116345
- **Lead sponsor:** Brian Jerkins, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05116345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05116345, "DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05116345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*